NCT06775808 Total Infectome Characterization of Eye Infections
| NCT ID | NCT06775808 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
| Condition | Eye Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-12-25 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-12-25 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multiple pathogens can cause eye infection. In recent years, emerging and resurging viral infections represent an important public health problem. Many emerging viruses cause infectious diseases involving ophthalmic manifestations, including Mpox virus, Zika, Ebola, and SARS-CoV-2. Broad and unbiased pathogen surveillance is essential, so we design this unbiased metagenomic sequencing based study to investigate the total infectome of eye infections. The study is historical and prospective in design.
Eligibility Criteria
Inclusion Criteria: 1. Patients with a clinical diagnosis of one or more types of eye infections (including acute conjunctivitis, keratitis, uveitis, and endophthalmitis). 2. Biological samples has been collected for clinical microbiological examination, or consented to participate in this study. Exclusion Criteria: 1\. Patients who have no historically clinical surplus specimens.
Contact & Investigator
Shuo Su, PhD
STUDY DIRECTOR
Fudan University
Frequently Asked Questions
Who can join the NCT06775808 clinical trial?
This trial is open to participants of all sexes, studying Eye Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06775808 currently recruiting?
Yes, NCT06775808 is actively recruiting participants. Contact the research team at mei.kang@shgh.cn for enrollment information.
Where is the NCT06775808 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06775808 clinical trial?
NCT06775808 is sponsored by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine. The principal investigator is Shuo Su, PhD at Fudan University. The trial plans to enroll 200 participants.